>"Drugmaker’s total revenues increased by 41% last year with help from $4bn Covid jab income"

>"Drugmaker says it expects to transition to ‘modest profitability’ as it receives new orders"

"The nuts and bolts of scaling up production matter more than intellectual property."

>"The British-Swedish drugmaker has joined with a huge Asian company to produce a Covid-19 vaccine in China, where shady reputations are common in the pharmaceutical industry."